Skip to main content
TOPICS
Videos
Provider
Payer
Pharma
Consumer
Investor
RESOURCES
Events
Jobs
Learning Center
Webinars
White Papers
REGIONS
ANZ
ASIA
EMEA
Global Edition
MORE
About
Advertise
Contact
Privacy Policy
ANZ
ASIA
EMEA
Global Edition
Coherus
Mark Cuban calls Yusimry's availability on MCCPDC 'a game changer'
By
Jessica Hagen
|
08:18 pm |
June 02, 2023
In a statement to MobiHealthNews, the cofounder of Mark Cuban Cost Plus Drug Company expressed excitement over the deal to offer the discounted Humira alternative.